IP Library Granted Patent US 9,561,042
Granted Patent B2
US 9,561,042 · App. 12/617,566 · Granted Feb 7, 2017

Methods and devices for delivering agents across biological barriers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,561,042
App. No.
12/617,566
Granted
Feb 7, 2017
Kind
B2
Abstract

The invention provides for microneedle devices for delivering agents across biological barriers. The microneedles include agent reservoirs integrated into the bodies of the microneedles, themselves.

Claims (29)

1. A device for delivering an agent across a biological barrier comprising:

a first microneedle comprising an integrated first reservoir which is an opening through the entirety of the width of the first microneedle and which comprises an agent stored in a dried or semi-solid state;

a first base element from which the first microneedle extends;

a substrate to which the first base element is coupled; and

a first depth guard that extends from the substrate and around a portion of the microneedle;

wherein a predetermined volume of the agent is contained predominantly within the interior volume of the microneedle; and

wherein the first microneedle, the substrate and the first depth guard are a monolithic single unit.

2. The device of claim 1 , wherein the first reservoir takes up a substantial portion of the volume of the first microneedle.

3. The device of claim 2 , wherein the first reservoir comprises between about 5% and about 70% of the volume of the first microneedle.

4. The device of claim 2 , wherein the first reservoir comprises about 20%-50% of the volume of the first microneedle.

5. The device of claim 1 , further comprising:

a second microneedle comprising an integrated second reservoir which is an opening through the entirety of one of the width and depth of the microneedle and which comprises an agent stored in a dried or semi-solid state;

a second base element from which the second microneedle extends, wherein the second base element is coupled to the substrate; and

a second depth guard that extends from the substrate;

wherein the second microneedle, the substrate and the second depth guard are a continuous single unit.

6. The device of claim 5 , wherein the first reservoir and the second reservoir contain the same agent.

7. The device of claim 5 , wherein the first reservoir contains a first agent and the second reservoir contains a different agent.

8. The device of claim 1 , wherein the agent is stored in a semi-solid gel-like state.

9. The device of claim 1 , wherein the first microneedle comprises one of stainless steel and titanium.

10. The device of claim 1 , wherein the first microneedle is between about 150 μm to about 3000 μm long.

11. The device of claim 1 , wherein the first microneedle is between about 300 μm to about 1500 μm long.

12. The device of claim 1 , wherein the first microneedle is about 10 μm to about 2000 μm wide.

13. The device of claim 1 , wherein the first microneedle is about 100 μm to about 500 μm wide.

14. The device of claim 1 , wherein the agent is suitable for intradermal delivery.

15. The device of claim 1 , wherein the first reservoir is filled with the agent.

16. The device of claim 1 wherein the first reservoir comprises between about 50%-70% of the volume of the first microneedle.

17. A method of delivering an agent across a biological barrier, wherein the method comprises:

providing the device of claim 1 ; and

applying the device against the skin of a patient, thereby piercing the skin and positioning the integrated reservoir beneath the surface of the skin.

Assignments (5)
SALE ORDER / RELEASE OF SECURITY INTEREST Recorded Aug 18, 2025
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: ZEALAND PHARMA A/S
Reel/Frame 072509/0386 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded May 28, 2013
From: VALERITAS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 030497/0800 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2010
From: MCALLISTER, DEVIN V.; DIMEGLIO, CIRO
To: BIOVALVE TECHNOLOGIES, INC.
Reel/Frame 024429/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2010
From: BIOVALVE TECHNOLOGIES, INC.
To: VALERITAS LLC
Reel/Frame 024429/0940 →
CHANGE OF NAME Recorded May 24, 2010
From: VALERITAS LLC
To: VALERITAS, INC.
Reel/Frame 024430/0028 →